Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Quantitative Evaluation of Safety in Drug Development : Design, Analysis and Reporting, Paperback / softback Book

Quantitative Evaluation of Safety in Drug Development : Design, Analysis and Reporting Paperback / softback

Edited by Qi Jiang, H. Amy Xia

Part of the Chapman & Hall/CRC Biostatistics Series series

Paperback / softback

Description

State-of-the-Art Methods for Drug Safety AssessmentResponding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development.

It presents the latest statistical methods for drug safety assessment.

The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis.

The book addresses key challenges across regulatory agencies, industry, and academia.

It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community.

It shares best practices and stimulates further research and methodology development in the drug safety area.

Information

Save 5%

£45.99

£43.25

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Chapman & Hall/CRC Biostatistics Series series  |  View all